{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 14, "transaction_limit": 160, "filters": {"q": "", "ticker": "CING", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 14, "acquisition_count": 14, "disposal_count": 0, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "flow_tone": "positive", "largest_value_label": "$0", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 14, "value": "0.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$0"}], "days": [{"transaction_date": "2026-06-30", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 7.7}, {"transaction_date": "2026-07-16", "acquisitions": 13, "disposals": 0, "total": 13, "bar_width": 100.0}], "side_mix": {"acquisitions": 14, "disposals": 0, "acquisition_share": 100.0, "disposal_share": 0.0}}, "company_flows": [{"symbol": "CING", "name": "Cingulate Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "acquisitions": 14, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}], "company_overview": [{"symbol": "CING", "name": "Cingulate Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "filings": 14, "acquisitions": 14, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}], "transactions": [{"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BRAMS, MATTHEW", "executive_title": "EVP and Chief Medical Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 53600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.606026+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BRAMS, MATTHEW", "executive_title": "EVP and Chief Medical Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 26400.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.607370+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CALLAHAN, JENNIFER L.", "executive_title": "EVP and CFO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 40200.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.611533+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CALLAHAN, JENNIFER L.", "executive_title": "EVP and CFO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 19800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.613687+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "DOWNEY, BRYAN WADE", "executive_title": "EVP & Chief Commercial Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 67000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.622245+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "DOWNEY, BRYAN WADE", "executive_title": "EVP & Chief Commercial Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 33000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.602186+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARGROVES, THOMAS JEFFREY", "executive_title": "Director", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.609529+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "LAWRENCE, BRYAN JAY", "executive_title": "Director", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.604362+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SCHAFFER, SHANE J.", "executive_title": "Director, Chief Executive Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 197650.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.598183+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SCHAFFER, SHANE J.", "executive_title": "Director, Chief Executive Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 97350.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.624552+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SILVA, RAUL R.", "executive_title": "EVP and CSO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 26400.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.620210+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SILVA, RAUL R.", "executive_title": "EVP and CSO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 53600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.618092+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "WERTH, PETER J.", "executive_title": "Director", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.615861+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "SILVA, RAUL R.", "executive_title": "EVP and CSO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 3885.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T11:08:31.390813+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}